by Vora Corporate Finance | Jan 4, 2025 | Insights
There were 15 main board IPOs in December 2024 of Suraksha Diagnostics Limited, as One Mobikwik Systems Limited, Sai Life Sciences Limited, Vishal Mega Mart Limited, Inventurus Knowledge Solutions LIMITED, International Gemmolgical Institue India Limited, Transrail...
by Vora Corporate Finance | Dec 30, 2024 | Insights
The International Monetary Fund (IMF) upgraded India’s GDP projections by 20 basis points to 7 percent, from previous estimate of 6.8 percent in April, reflecting carryover from upward revisions to growth in 2023 and improved prospects for private consumption,...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Merger & Acquisitions
Transaction: Ahead of the merger, Aster will purchase a 5.0% stake in Quality Care from Blackstone and TPG in consideration of primary share issuance by Aster for a 3.6% stake. Post the initial share acquisition, Quality Care will be merged into Aster by way of a...
by Vora Corporate Finance | Dec 16, 2024 | Insights
The BSE Sensex closed at 79,803 up by 0.52% and the Nifty 50 closed at 24,131 down by 0.31% in November 2024, driven by concerns over stretched valuations, weak performance by Indian Inc in Q2 and persistent selloffs by foreign investors. From a sector perspective,...
